How does HCT's PS Ratio compare to its peers?

HCT is good value based on its Price-To-Sales Ratio (0.6x) compared to the peer average (1.9x).

How does HCT's PS Ratio compare vs other companies in the Global Personal Products Industry?

HCT is good value based on its Price-To-Sales Ratio (0.6x) compared to the Global Personal Products industry average (1.5x).

What is HCT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate HCT's Price-To-Sales Fair Ratio for valuation analysis.

What is the Fair Price of HCT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate HCT's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

Holista Colltech (ASX:HCT) - Stock Price, News & Analysis

HCT Stock Overview

Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. More details

HCT fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Earnings have declined by 8.5% per year over past 5 years

Negative shareholders equity

Has less than 1 year of cash runway

Does not have a meaningful market cap (A$3M)

+ 2 more risks

Holista Colltech Limited Competitors

Nutritional Growth Solutions

ASX:NGS

AU$4.3m

Skin Elements

ASX:SKN

AU$2.3m

Elixinol Wellness

ASX:EXL

AU$7.8m

Anagenics

ASX:AN1

AU$3.7m

Price History & Performance

Summary of all time highs, changes and price drops for Holista Colltech
Historical stock prices
Current Share Price	AU$0.012
52 Week High	AU$0.027
52 Week Low	AU$0.004
Beta	0.12
11 Month Change	-50.00%
3 Month Change	-29.41%
1 Year Change	9.09%
33 Year Change	-77.78%
5 Year Change	-84.00%
Change since IPO	-90.77%

Recent updates

Shareholder Returns

	HCT	AU Personal Products	AU Market
7D	-20.0%	-2.2%	1.5%
1Y	9.1%	64.9%	17.2%

Return vs Industry: HCT underperformed the Australian Personal Products industry which returned 65.5% over the past year.

Return vs Market: HCT underperformed the Australian Market which returned 17.7% over the past year.

Price Volatility

Is HCT's price volatile compared to industry and market?
HCT volatility
HCT Average Weekly Movement	24.3%
Personal Products Industry Average Movement	5.5%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Stable Share Price: HCT's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: Insufficient data to determine HCT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	www.holistaco.com

Holista CollTech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Food Ingredients, and Infection Control Solutions segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes.

Holista Colltech Limited Fundamentals Summary

How do Holista Colltech's earnings and revenue compare to its market cap?
HCT fundamental statistics
Market cap	AU$3.35m
Earnings (TTM)	-AU$4.64m
Revenue (TTM)	AU$5.46m

0.6x

P/S Ratio

-0.7x

P/E Ratio

Is HCT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HCT income statement (TTM)
Revenue	AU$5.46m
Cost of Revenue	AU$3.20m
Gross Profit	AU$2.26m
Other Expenses	AU$6.89m
Earnings	-AU$4.64m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.017
Gross Margin	41.33%
Net Profit Margin	-84.97%
Debt/Equity Ratio	-35.9%

How did HCT perform over the long term?

See historical performance and comparison

HCT Stock Overview

Risk Analysis

Holista Colltech Limited Competitors

ASX:NGS

AU$4.3m

ASX:SKN

AU$2.3m

ASX:EXL

AU$7.8m

ASX:AN1

AU$3.7m

Price History & Performance

Recent News & Updates

Holista Colltech Limited, Annual General Meeting, May 31, 2024

Full year 2023 earnings released: AU$0.008 loss per share (vs AU$0.005 loss in FY 2022)

Less than half of directors are independent

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.002 loss in 1H 2022)

New major risk - Revenue and earnings growth

Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.005 loss in FY 2021)

Recent updates

Holista Colltech Limited, Annual General Meeting, May 31, 2024

Full year 2023 earnings released: AU$0.008 loss per share (vs AU$0.005 loss in FY 2022)

Less than half of directors are independent

First half 2023 earnings released: AU$0.004 loss per share (vs AU$0.002 loss in 1H 2022)

New major risk - Revenue and earnings growth

Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.005 loss in FY 2021)

First half 2022 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2021)

Holista Colltech Limited Announces Test Results on All-Natural Nano Silver Disinfectant

Less than half of directors are independent

Full year 2021 earnings released: AU$0.005 loss per share (vs AU$0.02 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Gara Group Files Lawsuit Against Holista Colltech, Ltd

Independent Non-Executive Chairman Daniel O’Connor has left the company

Non-Executive Director & Company Secretary Blair Michelson has left the company

Independent Non-Executive Director Heng Fai Chan has left the company

Holista Colltech Limited Reaches an Amicable Out-Of-Court Settlement with Eight Mercatus USA

Holista CollTech Limited Grants Permission Under Special Access Under the Medical Device

Holista Colltech Limited Updates on Legal Dispute

Full year 2020 earnings released: AU$0.02 loss per share (vs AU$0.003 loss in FY 2019)

Holista Terminates Term Sheet with Skin Elements

First half earnings released

Shareholder Returns

Price Volatility

About the Company

Holista Colltech Limited Fundamentals Summary

0.6x

-0.7x

Earnings & Revenue